A ABA training behavior modification techniques, 101, 106 UCLA model, 103 Acute Lymphoblastic Leukemia (ALL), 71, 78 Acute pain, 49, 51, 56 Adherence to diabetes regimens, 34 American Cancer Society, 71 American Psychologist, 81 Amphetamines, 175 Analgesics, 53, 55, 56, 60 Antisocial personality disorder, 153, 154 Anxiety, 121 124 assessment, 116 117 case study, 125 128 disease management, 117 119 DSM-5, 111 generalized anxiety disorder, 112 genetic and environmental influences, 114 health educators, 125 impact for children, 115 116 interventions adaptation, 121 CBT, 121, 124 computer training, 124 depressive symptoms, 123 evaluation, 124 exposure to anxiety-provoking stimuli, 122 internet-based interventions, 122 prevention program, 123 psychotherapy, 124 treatment, 122 types, 121 medications, 119 obsessive-compulsive disorder, 112 prevalence, children, 113, 114 psychosocial and emotional functioning, 120 121 school phobia, 113 Selective Mutism, 112 separation anxiety disorder, 112 social anxiety disorder, 112 specific phobia, 113 symptoms, triggers, 119 120 Applied Behavior Analysis Training. See ABA training ASD. See Autism spectrum disorder (ASD) Asthma adherence, 18, 19 CARAT, 15 case study, 24 27 chronic illness, 15 diagnosis, 13 14 disease management, 15, 16 educational interventions, 20 emotional and behavioral function, 21 genetic and environmental determinants, 14 health educators, 23 24 home-based intervention, 23 inhalers, 17 medical recommendations, 18, 19 mental health professionals, 23 24 prevalence, 14 psychosocial and emotional functioning, 19 20 school-based intervention, 22 self-management intervention, 22 symptoms, 18 Springer International Publishing Switzerland 2016 L. Nabors, Medical and Mental Health During Childhood, Springer Series on Child and Family Studies, DOI 10.1007/978-3-319-31117-3 203
204 Asthma (cont.) triggers for asthma symptoms, 17 Triple P Program, 21 Attention-deficit/hyperactivity disorder (ADHD), 5, 151, 154, 160, 162 aforementioned scales, 173 amphetamines, 175 case study, 182 184 CLAS program, 180 conduct problems, 172 definition, 169 diagnosis, 169 170 disease management, 173 175 emotional functioning, 176 177 executive functioning skills, 181 genetic and environmental influences, 170, 171 impulsive and negative behaviors, 172 inattentive and hyperactive-impulsive symptoms, 171 learning disorders, 171 medication management, 178 methylphenidate, 175, 177 MTA study, 177, 180 neurological symptoms, 171 oppositional behaviors, 172 organizational and planning abilities, 181 organizational skills training, 179 PATHKO treatment, 179, 180 prevalence rates, 170 171 psychosocial functioning, 176, 177 stimulant medications, 175, 178 symptoms, 169, 170 Autism spectrum disorder (ASD), 93, 94 ABA training, 100, 101 behavioral interventions, 99 behavior modification techniques, 103 CARS, 99 case study, 106 108 cognitive functioning, 97 communication skills, 100 diagnosis DSM-5, 94 intellectual/cognitive functioning, 93 social communication and social interaction, 93 DISCO, 98 echolalia, 96 emotional and behavioral problems, 102 genes influences, 95 maladaptive/negative behaviors, 103 manualized intervention, 104 M-CHAT, 98 prevalence rates, 95 psychotropic medications, 101 repetitive behaviors, 96 Resilience Builder Program, 104 106 sameness/routine, 97 self-stimulatory behaviors, 104 stereotypies, 96 UCLA model, 103 verbal and nonverbal behaviors, 98 B Behavioral training for children with ASD, 99 Behavior modification, 5 Brain tumors, 72 Bronfenbrenner s ecological systems Theory, 137 C Cancer adherence to medical regimens, 77 78 assessment, 77 brain tumors, 72 caregivers, 75, 76, 82, 83, 90 case study, 86 88 cells, 71 diagnosis, 71 72 genetic and environmental determinants, 73 health educators role, 85 86 impact on children, 73 75 impact on family caregivers, 75 76 medications, 77 prevalence, 72 73 psychological and social functioning of children, 78 79 treatment and research about interventions, 80 85 Caregivers, 75, 76, 82, 83, 90 CARS. See Childhood Autism Rating Scale (CARS) CART. See Child Asthma Risk Assessment Tool (CART) CASCADE. See Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE) Case study, JIA, 8, 9 CBT programs. See Cognitive-behavioral therapy (CBT) CD. See Conduct disorder (CD) Chemotherapy, 80 Child and Adolescent Psychiatric Assessment (CAPA), 138
205 Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE), 39 Child Asthma Risk Assessment Tool (CART), 15, 16 Child s chronic illness, 75 Childhood Autism Rating Scale (CARS), 99 Children s Oncology Group, 72, 79, 80, 90 Chronic illnesses diagnosis, 189 positive thinking and self-talk, 190 self-monitoring charts, 190 CLAS program, 180 Cognitive-behavioral techniques, 140 Cognitive-behavioral therapy (CBT) Penn Resiliency Program, 143 programs, 121 psychotherapy, 142 stressbusters, 142 Conduct disorder (CD) amygdala, 153 anger triggers, 156 Antisocial Personality Disorder, 154 Attention-Deficit Hyperactivity Disorder, 154 callous and unemotional traits, 160 case study, 164 165 emotional dysregulation and aggression, 160 emotion-focused coping program, 163 evidence-based interventions, 161 Fast Track Intervention, 162 hostile attribution, 161 hyporesponsiveness, 155 Incredible Years Program, 162, 163 modeling appropriate behaviors, 157 ODD, 152 pharmacological treatments, 159 positive time, 158 positive/negative emotional reaction, 161 prefrontal cortex activity, 153 prevalence rates, 153 problem-solving training, 156 prosocial behavior, 156 self-control techniques, 159 shaping appropriate behaviors, 158 symptoms, 155 teaching anger management skills, 158 thioridazine, 159 Coping with diabetes, 44 Council on Children with Disabilities (2007), 4 Counseling, 139 Counting carbohydrates, 37 D Depression in children, 138, 139, 142 case study, 144 146 CBT (see Cognitive-behavioral therapy (CBT) ) clinical assessment direct interviews, 138 health educators role, 138 rating scales, 138 steps, 138 structured interviews, 138 comorbid diagnoses, 137 diagnosis, 133, 134 genetic and environmental determinants, 136 impacts, 137 management (see Disease management ) medications, 141 prevalence, 134, 135 psychosocial difficulties, 137 racial/ethnic group differences, 135 and SES, 135 stressors, 136 symptoms, 135 Depressive symptoms physical symptoms, 139 psychological symptoms, 139 Diabetes mellitus adherence, 37 38 aerobic activities, 41 blood glucose levels, 34 CASCADE program, 39 case study, 43 45 DKA, 36 emotional functioning, 34 exercise, 41 group interventions, 39 guidelines, management, 35 HbA1c, 34, 42 hyperglycemia and hypoglycemia, 33, 36 insulin pump, 33 management and health outcomes, 42 nutrition, 34 prevalence, 32 33 psychosocial and emotional problem, 38 39 TEENCOPE study group, 40 thyroid and cardiac disease, 36 type 1 diabetes, 31 type 2 diabetes, 32 Diabetic ketoacidosis (DKA), 36 Diagnostic and Statistical Manual of Mental Disorders, 111, 169
206 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), 94, 98, 133 Diagnostic Interview for Social and Communication Disorders (DISCO), 98 DISCO. See Diagnostic Interview for Social and Communication Disorders (DISCO) Disease management cognitive-behavioral techniques, 140 counseling, 139 depressive symptoms, 139 double-blind trial, 141 medications, 139 pharmacotherapy, 141 placebo-controlled trial, 141 positive imagery, 140 positive self-talk, 140 randomized trial, 141 Disruptive Mood Dysregulation Disorder, 134 Distraction, 54 56, 63 DKA. See Diabetic ketoacidosis (DKA) DSM-5. See Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) E Echolalia, 96, 97 Ecological Systems Theory, 197 Effective Public Health Practice Project, 83 Elizabeth Kübler-Ross Foundation, 85 F Factors impacting children s pain experiences, 53 Family support, 196 Family Therapeutic Conversation Intervention (FAM-TCI), 82 Fast track intervention, 162 Functional analysis of behavior, 3 G Generalized anxiety disorder (GAD), 112 Genetics for Health Professionals in Cancer Care: From Principals to Practice, 73 H Health educators, 1, 74, 78, 85 87 communication and problem-solving skills, 144 consultation and meeting with teachers, 7, 8 positive self-talk, 143 primary prevention, 143 secondary prevention, 143 tertiary prevention, 143, 144 Health literacy, 78 HEPA filters. See High-efficiency particulate (HEPA) filters High-efficiency particulate (HEPA) filters, 23 Hostile attribution, 161 Hyperglycemia, 33, 36 Hypoglycemia, 33, 36, 38 Hyporesponsiveness, 155 I Imagery cognitive strategy, 57 coping strategies, 66 relaxation, 59 Immunosuppressive drugs, 73 Implementation of school plans, 7 Impulsivity, 156 Incredible Years Program, 162, 163 Individual education programs (IEPs), 74 special needs/disabilities, children, 4 steps, plan development, 4 Individualized health care plans (IHPs) academic needs, 6 children with diabetes, 6 Section 504 Plan, 6 Inhalers, 17 Insulin administration counting carbohydrates, 33 hyperglycemic episode, 36 medical recommendations, 38 International Classification of Mental and Behavioral Disorders System (ICD-10), 139 Interventions to improve behavioral functioning, 159 Interventions to support diabetes management, 39, 42 J Juvenile Idiopathic Arthritis (JIA)., 8
207 L Least restrictive environment (LRE), 3 Leukemia, 72 Longitudinal retrospective cohort study, 136 LRE. See Least restrictive environment (LRE) M Major depressive disorder, 133 Make-A-Wish Program, 85 Management of asthma symptoms, 16 Management of exercise and stress, 33 M-CHAT. See Modified Checklist for Autism in Toddlers (M-CHAT) Medications double-blind trial, 141 pharmacotherapy, 141 placebo-controlled trial, 141 randomized trial, 141 Mental health problems anxiety disorders, 191 co-occurring/comorbid learning problems, 193 externalizing problems, 191 internalizing problems, 190 problem-solving, 190, 192 social skills training, 192 STEPS model, 192 Methylphenidates, 175, 177 179 Modeling appropriate behaviors, 157 Modified Checklist for Autism in Toddlers (M-CHAT), 98 MTA study, 177, 178, 180 N National Health Interview Survey, 3 Negative self-talk, 140, 145 O Obsessive-compulsive disorder, 112 Oppositional defiant disorder (ODD), 152, 153, 162 P Pain, 55, 57 59 acute pain, 49 analgesics, 60 assessment, 53, 54 case study, 64 66 chronic illnesses, 49 depression, 64 emotional functioning, 60 62 environmental influences, 52, 53 genetic influences, 52, 53 management education, 53 management strategies biofeedback, 58 distraction and relaxation, 55 gentle touch, 59 hypnosis, 58 imagery, 57 psychological and behavioral treatments, 59 multicomponent interventions, 62 negative emotions, 54 prevalence rates, 52 psychosocial pain management strategies, 50 randomized controlled trails, 62 rehabilitation program, 63 types, 49 visual analog scales, 53 Palpable mass (tumor), 72 Parent Empowerment for Asthma Care (PEPAC) Program, 20 PATHKO training, 179, 180 Pediatric Blood and Cancer, 81 Penn Resiliency Program, 143 PEPAC Program. See Parent Empowerment for Asthma Care (PEPAC) Program Persistent depressive disorder, 134, 137 Pharmacotherapy, 141 Physical/mental impairment, 5 Positive developmental trajectory, 199 Positive self-talk, 140, 143 Prozac (fluoxetine), 141 R Rating scales, 138 Reactive airways disease. See Asthma Reciprocal determinism, 198 Reinforcement to change behavior, 101 Relaxation diaphragmatic breathing, 58 multicomponent treatment interventions, 62 Resilience Builder Program, 104, 105
208 S Schools and children with special health care needs case study, 8, 9 functional abilities, 2 health professionals, role, 2 LRE, 3 multidisciplinary team, 2 needs diagnosis, 2 special education team, 3 Section 504 Plans academic needs, 6 accommodation plans, 5 behavior modification, 6 guidelines, 5 IEPs, 5 IHPs, 6 physical/mental impairment definition, 5 Separation anxiety disorder (SAD), 112 Shaping appropriate behavior, 158 Sibling adjustment, 196 197 Social anxiety disorder, 112 Socioeconomic status (SES), 135 Special education team, 3 Specific phobia, 113 Spinal cord tumors, 73 Spirometry, 13 Stereotypies language behaviors, 96 repetitive behaviors, 102 verbal and nonverbal behaviors, 98 Stimulant medications, 175, 178 Stressbusters, 142 Suicidal ideation, 139 Surviving Cancer Competently Intervention Program, 84 Systems approach, 193 195 T TEENCOPE study group, 40 Transmission of pain in children, 49 Triggers of an asthma attack, 17 Triple P Program, 21 Type 1 diabetes mellitus, 31 B cells, 31 management, 34 polydipsia and polyuria, 31 Type 2 diabetes mellitus, 32 U UCLA model, 103 V Verbal and nonverbal behaviors, 98 W White blood cells (lymphocytes), 71